85 milioane euro. Ucrainenii de la Biopharma își dublează investiția în fabrica de medicamente de la Oradea (FOTO)

Ukrainian pharmaceutical producer Biopharma is doubling its investment in Oradea, with the first phase costing 85 million euros. The project will be completed in four stages, with production expected to start in December 2027. The factory will process up to 1.2 million liters of frozen human plasma annually, creating at least 70 new jobs.